Universidad de Barcelona
Barcelona, 08185, Spain
Location status: Recruiting
NCT Number: NCT05288140
Randomized clinical trial that aims to evaluate the impact of the use of a diary in patients and relatives of patients admitted to an ICU in relation to usual practice in terms of health-related quality of life, the post-traumatic stress and anxiety/depression at 2, 6 and 12 months after ICU discharge.
Interested in participating?
Request Info18 year–100 year
All sexes
Interventional
Not applicable
Barcelona, 08185, Spain
Location status: Recruiting
Randomized, parallel, open, non-blinded, multicenter clinical trial, with an experimental group (diary) and a control group (usual practice), to compare the effect produced on quality of life by post-traumatic stress and anxiety/depression of patients and relatives, whether or not they have access to a diary during the stay in the unit. Three validated scales will be used at three different times. 120 cases per group, carrying out a preliminary pilot test. Data analysis according to IBM SPSS v.24 to describe and compare both groups.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
a diary is made for the experimental group where the events and events during the period of sedation and intubation are explained
Time frame: 2 months
questionnaries, range of 0-21 for either anxiety and depression subscores. Higher scores corresponding to worse outcomes. 0-7 normal; 8-10 borderline abnormal; 11-21 sever symptoms of anxiety or depressin.
Time frame: 6 months
questionnaries, range of 0-21 for either anxiety and depression subscores. Higher scores corresponding to worse outcomes. 0-7 normal; 8-10 borderline abnormal; 11-21 sever symptoms of anxiety or depressin.
Time frame: 12 months
questionnaries, range of 0-21 for either anxiety and depression subscores. Higher scores corresponding to worse outcomes. 0-7 normal; 8-10 borderline abnormal; 11-21 sever symptoms of anxiety or depressin.
Time frame: 2 months
questionnaries to measure quality of life. 36 items. from 0 to 100, with 100 being the best health
Time frame: 6 months
questionnaries to measure quality of life. 36 items. from 0 to 100, with 100 being the best health
Time frame: 12 months
questionnaries to measure quality of life. 36 items. from 0 to 100, with 100 being the best health
Time frame: 2 months
questionnaries; measuring areas of hyperarousal, avoidance, and intrusion as subscales. Total score ranges from 0-88, higher score associated with worse PTSD symptoms. 1-22 mild PTSD,;22 signal clinically significant PTSD symptoms.
Time frame: 6 months
questionnaries; measuring areas of hyperarousal, avoidance, and intrusion as subscales. Total score ranges from 0-88, higher score associated with worse PTSD symptoms. 1-22 mild PTSD,;22 signal clinically significant PTSD symptoms.
Time frame: 12 months
questionnaries; measuring areas of hyperarousal, avoidance, and intrusion as subscales. Total score ranges from 0-88, higher score associated with worse PTSD symptoms. 1-22 mild PTSD,;22 signal clinically significant PTSD symptoms.
Contact information is provided by the study sponsor or research team.
University of Barcelona
Other
Acronym: QUADERN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06652503
Anxiety, Anxiety Disorders
Fort Lauderdale, Florida, United States
View Trial DetailsNCT06423417
Anxiety, Anxiety Disorders
Amsterdam, Netherlands
View Trial DetailsNCT07561515
Acoustic Resonance, Anxiety
Belo Horizonte, Minas Gerais, Brazil
View Trial DetailsNCT07376395
Anxiety, Anxiety Disorders
Istanbul, Turkey (Türkiye)
View Trial Details